Table 1.

Sample characteristics, percentage reporting preference for another method in the absence of cost by characteristics, and prevalence ratios assessing association between characteristics and preference for another method in the absence of cost, 2015–2017 NSFG

	Descriptive statistics (n = 2744)		Prevalence ratios
	Sample characteristics, %a	Prefer another method in the absence of cost, %b	Unadjusted	(95% CI)	Adjusted	(95% CI)
All	100	22	–	–	–	–
Current contraceptive method
Pill/patch/ring	20	16	1 (ref)	–	1 (ref)	–
Female sterilization	18	19	1.15	(0.74–1.79)	1.12	(0.71–1.76)
Male sterilization	7	16	0.95	(0.55–1.65)	1.20	(0.66–2.15)
Implant	4	18	1.12	(0.70–1.78)	0.84	(0.52–1.36)
IUD	13	10	0.62	(0.36–1.09)	0.64	(0.37–1.10)
Injectable	2	21	1.29	(0.82–2.02)	1.11	(0.71–1.72)
Condom/withdrawal	25	30	1.86	(1.35–2.56)	1.75	(1.30–2.36)
None	12	36	2.19	(1.61–2.98)	1.94	(1.48–2.56)
Race/ethnicity
White, non-Hispanic	60	17	1 (ref)	–	1 (ref)	–
Black, non-Hispanic	13	28	1.64	(1.19–2.25)	1.35	(1.01–1.81)
Hispanic	21	29	1.73	(1.31–2.30)	1.48	(1.13–1.94)
Other, non-Hispanic	6	31	1.84	(1.16–2.93)	1.63	(1.00–2.65)
Age
15–24	24	29	1 (ref)	–	1 (ref)	–
25–34	40	22	0.76	(0.61–0.94)	0.87	(0.71–1.06)
35–44	37	18	0.62	(0.49–0.78)	0.75	(0.59–0.95)
Household income (as % of federal poverty level)
< 100%	21	29	1.77	(1.34–2.34)	1.45	(1.15–1.83)
100%–199%	23	24	1.47	(1.04–2.06)	1.22	(0.89–1.66)
200%–299%	16	24	1.45	(1.05–2.01)	1.35	(0.99–1.83)
≥ 300%	40	16	1 (ref)	–	1 (ref)	–
Insurance coverage
Privately insured	64	19	1 (ref)	–	1 (ref)	–
Publicly insured	22	24	1.29	(0.98–1.71)	1.02	(0.77–1.36)
Uninsured	14	33	1.77	(1.34–2.35)	1.29	(0.96–1.75)

Values are from Poisson regression and are weighted to account for the NSFG survey design. Adjusted results include all variables in a single model. CI, confidence interval.

^aColumn percentages.

^bRow percentages.